Galliprant in Dogs

Galliprant is the brand name for grapiprant, a prescription anti-inflammatory medication used in dogs. It is FDA-approved to control pain and inflammation associated with osteoarthritis. That matters because arthritis is one of the most common reasons older dogs slow down, hesitate on stairs, struggle to rise, or seem less interested in walks and play.

Galliprant is part of the NSAID family, but it works differently from many older canine NSAIDs. Instead of broadly blocking cyclooxygenase pathways, it targets the EP4 receptor involved in osteoarthritis pain and inflammation. For some dogs, that makes it a useful option when your vet wants arthritis relief with a more targeted mechanism.

This medication does not cure arthritis or rebuild damaged cartilage. It helps manage discomfort so daily life is easier. Many dogs take it as one piece of a broader plan that may also include weight control, physical rehabilitation, home traction changes, joint supplements, and other pain-support medications chosen by your vet.

Galliprant is not right for every dog. Safe use has not been established in dogs younger than 9 months, dogs under 8 pounds, breeding dogs, pregnant or lactating dogs, or dogs with cardiac disease. Your vet may also be more cautious if your dog has a history of stomach upset, liver or kidney concerns, or takes other medications that can interact with NSAIDs.

Galliprant works by blocking the prostaglandin E2 EP4 receptor. This receptor plays a major role in canine osteoarthritis pain and inflammation. Because grapiprant targets EP4 rather than broadly inhibiting COX enzymes the way many traditional NSAIDs do, it is often described as a more targeted NSAID option.

In practical terms, the goal is to reduce joint pain and improve comfort with movement. Pet parents may notice benefits such as easier rising, less stiffness after rest, better willingness to walk, and less limping. Response time varies. Some dogs improve within a few days, while others need a longer trial and a recheck with your vet to decide whether the medication is helping enough.

Galliprant is approved specifically for osteoarthritis pain and inflammation in dogs. It is not labeled for routine post-operative pain control the way some other canine NSAIDs are. That distinction is important when your vet is choosing among medication options for a specific problem.

Because arthritis is chronic, Galliprant is often used long term. Even so, your vet will usually aim for the lowest effective dose and will monitor your dog over time. Follow-up exams and periodic lab work help your vet balance comfort, function, and medication safety.

The most commonly reported side effects with Galliprant are digestive. These can include vomiting, diarrhea, soft stools, decreased appetite, and sometimes mucus or blood in the stool. Some dogs also seem more tired than usual. Mild stomach upset may pass, but ongoing vomiting, black stools, bloody diarrhea, marked lethargy, or refusal to eat should prompt a call to your vet right away.

Like other NSAIDs, Galliprant still deserves careful monitoring even though its mechanism is more targeted. Your vet may recommend baseline bloodwork and urinalysis before starting treatment, especially in older dogs or dogs with other medical conditions. If your dog stays on Galliprant long term, periodic rechecks help monitor liver and kidney values and make sure the medication is still a good fit.

Some dogs should use Galliprant more cautiously. That includes dogs with a known hypersensitivity to grapiprant and dogs with the MDR1 gene mutation, where medication handling may differ. Pet parents of Collies, Shelties, Australian Shepherds, and related breeds should mention breed background to their vet if MDR1 status is unknown.

See your vet immediately if your dog develops facial swelling, hives, collapse, severe weakness, repeated vomiting, tarry stool, or sudden behavior changes after starting Galliprant. Those signs can point to a serious reaction or another urgent problem that should not be managed at home.

Galliprant is given by mouth once daily. The FDA approval documents list a target dose of 2 mg/kg, which is about 0.9 mg/lb, every 24 hours. Tablets are available in 20 mg, 60 mg, and 100 mg strengths, and your vet will match the tablet size to your dog’s body weight and treatment plan.

The medication may be given with or without food, but food can reduce absorption. In real-world practice, your vet may still suggest giving it with a small meal if your dog has a sensitive stomach. That is one reason dosing directions should come from your vet and the prescription label, not from another dog’s plan or an online chart alone.

If you miss a dose, contact your vet for guidance. In many cases, the advice is to give the dose when remembered unless it is close to the next scheduled dose. Do not double up unless your vet specifically tells you to. More is not safer, and extra NSAID exposure can increase the risk of side effects.

Galliprant should be stored at room temperature and kept out of reach of pets and children. Because arthritis plans often change over time, do not adjust the dose, split tablets differently, or stop and restart the medication without checking with your vet first.

The most important interaction rule with Galliprant is to avoid combining it with other NSAIDs or corticosteroids unless your vet has given a specific plan. Pairing Galliprant with medications such as carprofen, meloxicam, deracoxib, firocoxib, aspirin, prednisone, or dexamethasone can raise the risk of stomach ulceration, bleeding, and other complications.

Your vet also needs to know about every other medication and supplement your dog takes. That includes joint products, fish oil, herbal products, gabapentin, trazodone, seizure medications, and anything bought over the counter. Not every combination is unsafe, but your vet needs the full list to judge risk, timing, and monitoring needs.

Dogs with liver disease, kidney disease, dehydration, a history of GI ulceration, or complex chronic illness may need a different plan or closer follow-up. In those cases, your vet may discuss conservative care with non-drug support, a standard NSAID plan with monitoring, or a more advanced multimodal pain strategy depending on your dog’s needs and your goals.

Before starting Galliprant, ask your vet whether baseline bloodwork and urinalysis are recommended. For long-term use, periodic lab monitoring is common. That step helps catch problems early and gives your vet better information if your dog’s appetite, stool quality, thirst, or energy changes during treatment.